Kinetics of HBsAg forms in chronic hepatitis delta patients treated with bulevirtide for 48 weeks: correlation with virological response

被引：0
|
作者：
D'Anna, Stefano [1 ]
Salpini, Romina [1 ]
Degasperi, Elisabetta [2 ]
Duca, Leonardo [1 ,3 ]
Anolli, Maria Paola [2 ]
Piermatteo, Lorenzo [1 ]
Sambarino, Dana [2 ]
Borghi, Marta [2 ]
Facchetti, Floriana [2 ]
Silberstein, Francesca Ceccherini [1 ]
Perbellini, Riccardo [2 ]
Svicher, Valentina [1 ,3 ]
Lampertico, Pietro [2 ,4 ]
机构：
[1] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, Milan, Italy
[3] Univ Roma Tor Vergata, Dept Biol, Rome, Italy
[4] CRC AM & A Migliavacca Ctr Liver Dis, Dept Pathophysiol & Transplantat, Milan, Italy
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-159
引用
收藏
页码：S1142 / S1142
页数：1
相关论文
共 50 条
  • [21] Real-life experiences with bulevirtide for the treatment of hepatitis delta-48 weeks data from a German centre
    Zoellner, Caroline
    Hofmann, Joerg
    Lutz, Katrin
    Tacke, Frank
    Demir, Muenevver
    LIVER INTERNATIONAL, 2022, 42 (11) : 2403 - 2407
  • [22] Entecavir induced HBV DNA suppression at 12 weeks in treatment-naive patients with chronic hepatitis B is a good predictive factor for virological response at 48 weeks
    Kim, H. J.
    Lee, J. H.
    Lee, J. S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A281 - A281
  • [23] ENTECAVIR INDUCED HBV DNA SUPPRESSION AT 12 WEEKS IN TREATMENT-NAVIE PATIENTS WITH CHRONIC HEPATITIS B IS A GOOD PREDICTIVE FACTOR FOR VIROLOGICAL RESPONSE AT 48 WEEKS
    Lee, Hyun Woong
    Kim, Hyung Joon
    Kim, Min Hwan
    Kim, Kyung-ah
    Lee, June Sung
    Sul, Hye Ryung
    Chung, Sun Joo
    Hwang, Seung Jae
    Choi, Chang Hwan
    Kim, Jung Uk
    Do, Joe Hyuk
    Kim, Jae Kyu
    Chang, Sae Kyung
    Park, Sill Moo
    HEPATOLOGY, 2008, 48 (04) : 741A - 742A
  • [24] Virological and clinical characteristics of chronic hepatitis delta patients of Mongolia
    Zulkhuu, Delgersaikhan
    Dashtseren, Bekhbold
    Budeebazar, Myagmarjav
    Enkhbat, Maralmaa
    Eichner, Miriam
    Bat-Ulzii, Purevjargal
    Genden, Zulkhuu
    Mordorjyn, Altankhuu
    Yagaanbuyant, Dahgwahdorj
    Dashdorj, Naranbaatar
    Bungert, Andreas
    Dashdorj, Naranjargal
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E272 - E273
  • [25] Early virological response in six patients with hepatitis D virus infection and compensated cirrhosis treated with Bulevirtide in real-life
    Asselah, Tarik
    Loureiro, Dimitri
    Le Gal, Frederic
    Narguet, Stephanie
    Brichler, Segolene
    Bouton, Valerie
    Abazid, Malek
    Boyer, Nathalie
    Giuly, Nathalie
    Gerber, Athenais
    Tout, Issam
    Maylin, Sarah
    Bed, Cheikh M.
    Marcellin, Patrick
    Castelnau, Corinne
    Gordien, Emmanuel
    Mansouri, Abdellah
    LIVER INTERNATIONAL, 2021, 41 (07) : 1509 - 1517
  • [26] IMPROVEMENT OF CLINICAL PARAMETERS IN HDV PATIENTS WITH ADVANCED COMPENSATED CIRRHOSIS TREATED WITH BULEVIRTIDE MONOTHERAPY FOR 48 WEEKS
    Degasperi, Elisabetta
    Anolli, Maria Paola
    Renteria, Sara Colonia Uceda
    Sambarino, Dana
    Borghi, Marta
    Perbellini, Riccardo
    Facchetti, Floriana
    Loglio, Alessandro
    Monico, Sara
    Fraquelli, Mirella
    Costantino, Andrea
    Ceriotti, Ferruccio
    Lampertico, Pietro
    HEPATOLOGY, 2022, 76 : S216 - S217
  • [27] Rapid virological & End treatment response of patients treated with Sofosbuvir in Chronic Hepatitis C
    Siddique, Muhammad Shoaib
    Shoaib, Sana
    Saad, Alvia
    Iqbal, Hamna Javed
    Durrani, Noureen
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2017, 33 (04) : 813 - 817
  • [28] Improvement of clinical parameters in HDV patients with advanced compensated cirrhosis treated with Bulevirtide monotherapy for 48 weeks
    Degasperi, E.
    Anolli, M. P.
    Renteria, S. C. Uceda
    Sambarino, D.
    Borghi, M.
    Perbellini, R.
    Facchetti, F.
    Loglio, A.
    Monico, Sara
    Fraquelli, M.
    Costantino, A.
    Ceriotti, F.
    Lampertico, P.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S29 - S29
  • [29] Clevudine-induced HBV DNA suppression at 24 weeks in treatment-naive patients with chronic hepatitis B is a good predictive factor for virological response at 48 weeks
    Lee, H. W.
    Kim, H. J.
    Kim, K. A.
    Lee, J. S.
    Baek, E. K.
    Kim, K. S.
    Cha, B. K.
    Oh, H. C.
    Choi, C. H.
    Kim, J. W.
    Do, J. H.
    Kim, J. G.
    Chang, S. K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A169 - A169
  • [30] Bulevirtide efficacy and safety in chronic hepatitis delta patients on liver transplant waiting list
    Meszaros, Magdalena
    Hilleret, Marie-Noelle
    Dumortier, Jerome
    Dalteroche, Louis
    Abergel, Armand
    Latournerie, Marianne
    Antonini, Teresa
    Conti, Filomena
    Borentain, Patrick
    Kamar, Nassim
    Besch, Camille
    Francoz, Claire
    Debette-Gratien, Maryline
    Dharancy, Sebastien
    Pageaux, Georges-Philippe
    JOURNAL OF HEPATOLOGY, 2024, 80 : S763 - S764
12345